YUCAIPA, Calif., Jan. 28, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:ITEC) announced today that Company CEO Scott Sand appeared in a recent installment of CEOCorner, "The Fastest 60 Seconds in the Small Cap Market." Mr. Sand consented to the interview in order to provide shareholders and prospective shareholders with updates and a brief inside look at the most compelling features and recent developments of Ingen Technologies. Details of the interview can be heard at the company profile for Ingen Technologies on the InvestSource, Inc. (ISI) website at: www.investsourceinc.com or on the CEOCorner website at: www.ceo-corner.com.
Over the course of the interview, Mr. Sand stressed in particular the features and benefits of his Company's innovative medical products. He pointed out that the unique technology behind the Oxyview(r) puts the Company in a position virtually free of competition in the respiratory device market. Mr. Sand was very confident that Ingen was well positioned with its present distribution channels throughout North America, as well as Asia and the Middle East. He also was keen to discuss some of the additional technologies, all manufactured in the United States, that the Company will be bringing to market in the future, all of which are part of Ingen's larger plans to continue to expand into the large and growing market for respiratory devices.
For more information please visit: http://www.ingen-tech.com
About Ingen Technologies, Inc.
Ingen is an established medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the U.S., and $8 billion globally. The company introduced Oxyview(r) into the respiratory market in late 2007 after securing U.S. and Foreign Patents and successful licensing with the Food & Drug Administration, and has commenced domestic and global distribution with manufacture representative organizations, and OEM partners. In addition to selling its respiratory products within the global medical industry, the company is selling the same products within other industries that include aviation, automotive, emergency response, military and government transportation. The company holds a Device Manufacturing License with the State of California, Department of Public Health, Food and Drug Branch as it manufacturers all of its respiratory products in the United States. There are 32 million U.S. patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide. Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.
The Ingen Technologies, Inc. logo is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=2472
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.